About
Pierre Moustial is a healthtech executive and dealmaker who previously served as CEO of Urgo, which he grew from €30m to €700m in revenue through innovation and M&A, and as CEO of Fournier Pharma, which he sold to Solvay for €1.3bn. He started his career as a finance instructor and healthtech merchant banker at Paribas. He is Chairman Emeritus of the MedTech industry association in France and holds a degree from HEC Paris.
Invests in
HealthtechMedical Devices
Colleagues at Lauxera Capital Partners
Adrian Péfau
Analyst at Lauxera Capital Partners
Alessandra Malaval
Investment Manager at Lauxera Capital Partners
Alex Slack
Co-founding Partner at Lauxera Capital Partners
Anaïs Raevel
Analyst at Lauxera Capital Partners
Anna Yang
CFO & Head of Operations at Lauxera Capital Partners
Delphine Leduc
Office Manager at Lauxera Capital Partners
Edoardo Fracchia
Partner at Lauxera Capital Partners
Lise de Courville
Head of Investor Relations & ESG at Lauxera Capital Partners